[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Reza et al., 2021 - Google Patents

In situ single cell proteomics reveals circulating tumor cell heterogeneity during treatment

Reza et al., 2021

Document ID
11694073615583350962
Author
Reza K
Dey S
Wuethrich A
Wang J
Behren A
Antaw F
Wang Y
Sina A
Trau M
Publication year
Publication venue
ACS nano

External Links

Snippet

Cancer is a dynamic disease with heterogenic molecular signatures and constantly evolves during the course of the disease. Single cell proteomic analysis could offer a suitable pathway to monitor cancer cell heterogeneity and deliver critical information for the …
Continue reading at pubs.acs.org (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means

Similar Documents

Publication Publication Date Title
Reza et al. In situ single cell proteomics reveals circulating tumor cell heterogeneity during treatment
Panikar et al. Towards translation of surface-enhanced Raman spectroscopy (SERS) to clinical practice: Progress and trends
Poudineh et al. Profiling circulating tumour cells and other biomarkers of invasive cancers
Zhang et al. Dual-multivalent-aptamer-conjugated nanoprobes for superefficient discerning of single circulating tumor cells in a microfluidic chip with inductively coupled plasma mass spectrometry detection
Sinkala et al. Profiling protein expression in circulating tumour cells using microfluidic western blotting
Lv et al. Label-free exosome detection based on a low-cost plasmonic biosensor array integrated with microfluidics
Wilson Jr et al. Immunomagnetic capture and multiplexed surface marker detection of circulating tumor cells with magnetic multicolor surface-enhanced Raman scattering nanotags
Lu et al. NanoVelcro Chip for CTC enumeration in prostate cancer patients
Pei et al. Single-cell phenotypic profiling of CTCs in whole blood using an integrated microfluidic device
Lu et al. Biotin-triggered decomposable immunomagnetic beads for capture and release of circulating tumor cells
Zhao et al. Chemiluminescence resonance energy transfer-based detection for microchip electrophoresis
Zhao et al. An automated high-throughput counting method for screening circulating tumor cells in peripheral blood
Powers et al. Protein analytical assays for diagnosing, monitoring, and choosing treatment for cancer patients
Wu et al. Chip-assisted single-cell biomarker profiling of heterogeneous circulating tumor cells using multifunctional nanospheres
Yu et al. Design of a biocompatible and ratiometric fluorescent probe for the capture, detection, release, and reculture of rare number CTCs
Yang et al. Single-cell, multiplexed protein detection of rare tumor cells based on a beads-on-barcode antibody microarray
Xu et al. Quantum dot-based, quantitative, and multiplexed assay for tissue staining
Fan et al. Ultrasensitive exosome detection by modularized SERS labeling for postoperative recurrence surveillance
Wang et al. Characterizing the heterogeneity of small extracellular vesicle populations in multiple cancer types via an ultrasensitive chip
Lu et al. Fabrication of a polyvalent aptamer network on an electrode surface for capture and analysis of circulating tumor cells
Wang et al. Single-cell analysis and classification according to multiplexed proteins via microdroplet-based self-driven magnetic surface-enhanced raman spectroscopy platforms assisted with machine learning algorithms
Stepula et al. 6-color/1-target immuno-SERS microscopy on the same single cancer cell
Litti et al. SERRS multiplexing with multivalent nanostructures for the identification and enumeration of epithelial and mesenchymal cells
Neoh et al. pH-responsive carbon nanotube film-based microfluidic chip for efficient capture and release of cancer cells
Baird et al. Tumor cell detection by mass spectrometry using signal ion emission reactive release amplification